Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EY0573 / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Blood pressure decreased, Blood pressure increased, Body temperature, Heart rate, Heart rate increased, Oxygen saturation, Pallor, Presyncope, Seizure, Blood pressure measurement
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data: Test Date: 20210910; Test Name: Blood pressure; Result Unstructured Data: Test Result:86/72 mmHg; Comments: 11:02; Test Date: 20210910; Test Name: Blood pressure; Result Unstructured Data: Test Result:146/80 mmHg; Comments: 11:10; Test Date: 20210910; Test Name: body temperature; Result Unstructured Data: Test Result:36.2 Centigrade; Test Date: 20210910; Test Name: pulse test; Result Unstructured Data: Test Result:142; Comments: 11:02; Test Date: 20210910; Test Name: Oxygen saturation; Test Result: 96 %; Comments: 11:02; Test Date: 20210910; Test Name: Oxygen saturation; Test Result: 98 %; Comments: 11:10
CDC 'Split Type': JPPFIZER INC202101198430
Write-up: Blood pressure 146/80; Blood pressure 86/72; Heart rate 142; Convulsion; Pallor facial; vagal relex/ Vasovagal reaction; This is a spontaneous report from a contactable physician received from the regulatory authority. Regulatory authority report number is v21126526. The patient was a 17-year-old male. Body temperature before vaccination was 36.2 degrees Centigrade on 10Sep2021. Medical history was not reported. The patient previously took DPT vaccine for immunisation and experienced swelling in armpit. Concomitant medication was not reported. On 10Sep2021 at 10:45 (the day of vaccination), the patient received the first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot number EY0573, Expiration date 30Sep2021) via an unspecified route of administration as a single dose at 17-year-old for COVID-19 immunization. On 10Sep2021 at 11:00 (15 minutes after the vaccination), the patient experienced vasovagal reaction. The course of the event was as follows: At 10:55, the patient received vaccination. At 11:00, the symptoms of convulsion, pallor facial and vagal relex occurred. At 11:02, BP 86/72, Pulse 142, Oxygen saturation 96%. At 11:10, the symptom of convulsion subsided. BP 146/80, Oxygen saturation 98%. On 10Sep2021 (the day of vaccination), the outcome of the events was recovered. The reporting physician classified the event as non-serious and assessed that the event was related to bnt162b2. Other possible cause(s) of the event such as any other diseases was illegible characters. The reporting physician commented as follows: When receiving the second dose of vaccination, it was necessary to lay down and after that have an observation of 30 minutes.; Reporter''s Comments: When receiving the second dose of vaccination, it was necessary to lay down and after that have an observation of 30 minutes.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166